Back to all News

Imperial Brands Ventures Ltd announces investment in Oxford Cannabinoid Technologies

Imperial Brands Ventures Ltd, a subsidiary of Imperial Brands PLC, today announces that it has taken an equity stake in Oxford Cannabinoid Technologies (OCT).

OCT is a biopharmaceutical company focused on researching, developing, and licensing cannabinoid-based compounds and therapies. Its activities are licensed for operation by the UK Home Office.

Matthew Phillips, Chief Development Officer, Imperial Brands PLC said: “We are pleased to be partnering with OCT. Cannabinoid products have significant potential and our investment enables Imperial to support OCT’s important research while building a deeper understanding of the medical cannabis market.”

ENDS

Notes to editors

Imperial Brands is a dynamic fast moving consumer goods company borne out of a strong tobacco heritage. We have continually evolved to embrace changing market dynamics and are increasingly focusing our attention on developing and expanding our portfolio of Next Generation Products.

Investor contacts   Media contacts  
Peter Durman +44 (0)7970 328 903 Alex Parsons +44 (0)7967 467 241
Matt Sharff +44 (0)117 933 7396 Simon Evans +44 (0)7967 467 684